Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (51-60 of 380) with videos related to

Pageof 38
Sort By:
Hematological Oncology|December 1, 2023
Classic Hodgkin lymphomaJustine Kahn, Bouthaina Dabaja, Susan Wu, et al.
Bone Marrow Transplantation|March 28, 2025
Lymphodepletion chemotherapy in chimeric antigen receptor-engineered T (CAR-T) cell therapy in lymphomaMarta Canelo-Vilaseca, Mohamad Sabbah, Roberta Di Blasi, et al.
Transplantation and Cellular Therapy|January 28, 2024
Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-AnalysisNico Gagelmann, Michael Bishop, Francis Ayuk, et al.
Leukemia & Lymphoma|May 18, 2016
Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuationBastian von Tresckow, Franck Morschhauser, Jeffrey Szer, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 4, 2025
Impact of the national blackout of April 28, 2025 on processing facilities for hematopoietic stem cell transplantation and cell therapy in SpainOscar M Pello, Maria E Martinez-Muñoz, Jose Luis Arroyo, et al.
Croatian Medical Journal|July 5, 2016
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host diseaseIsabel Sánchez-Ortega, Rocío Parody, Octavio Servitje, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host diseaseJose Luis Piñana, David Valcárcel, Rodrigo Martino, et al.
Cancers|February 15, 2022
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Tisagenlecleucel for the Management of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in SpainMariana Bastos-Oreiro, Ana de Las Heras, María Presa, et al.
Leukemia & Lymphoma|July 16, 2009
Advances in mobilization for the optimization of autologous stem cell transplantationJulie M Vose, Anthony D Ho, Bertrand Coiffier, et al.
British Journal of Haematology|June 3, 2006
Darbepoetin-alpha for the anaemia of myelofibrosis with myeloid metaplasiaFrancisco Cervantes, Alberto Alvarez-Larrán, Juan-Carlos Hernández-Boluda, et al.
Pageof 38

Showing results (51-60 of 380) with videos related to

Sort By:
Pageof 38
Hematological Oncology|December 1, 2023
Classic Hodgkin lymphomaJustine Kahn, Bouthaina Dabaja, Susan Wu, et al.
Bone Marrow Transplantation|March 28, 2025
Lymphodepletion chemotherapy in chimeric antigen receptor-engineered T (CAR-T) cell therapy in lymphomaMarta Canelo-Vilaseca, Mohamad Sabbah, Roberta Di Blasi, et al.
Transplantation and Cellular Therapy|January 28, 2024
Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-AnalysisNico Gagelmann, Michael Bishop, Francis Ayuk, et al.
Leukemia & Lymphoma|May 18, 2016
Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuationBastian von Tresckow, Franck Morschhauser, Jeffrey Szer, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 4, 2025
Impact of the national blackout of April 28, 2025 on processing facilities for hematopoietic stem cell transplantation and cell therapy in SpainOscar M Pello, Maria E Martinez-Muñoz, Jose Luis Arroyo, et al.
Croatian Medical Journal|July 5, 2016
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host diseaseIsabel Sánchez-Ortega, Rocío Parody, Octavio Servitje, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host diseaseJose Luis Piñana, David Valcárcel, Rodrigo Martino, et al.
Cancers|February 15, 2022
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Tisagenlecleucel for the Management of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in SpainMariana Bastos-Oreiro, Ana de Las Heras, María Presa, et al.
Leukemia & Lymphoma|July 16, 2009
Advances in mobilization for the optimization of autologous stem cell transplantationJulie M Vose, Anthony D Ho, Bertrand Coiffier, et al.
British Journal of Haematology|June 3, 2006
Darbepoetin-alpha for the anaemia of myelofibrosis with myeloid metaplasiaFrancisco Cervantes, Alberto Alvarez-Larrán, Juan-Carlos Hernández-Boluda, et al.
Pageof 38